Jianfeng Group 2014 Annual Profit Distribution Implementation Announcement
Release time:
2020-08-05
Securities Code: 600668 Securities Abbreviation: Jianfeng Group Announcement No.: Pro 2015-018
Bond Abbreviation: 13 Peak 01 Bond Code: 122227
Bond Abbreviation: 13 Peak 02 Bond Code: 122344
Zhejiang Jianfeng Group Co., Ltd.
2014 Profit Distribution Implementation Announcement
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and assume individual and joint responsibility for the truthfulness, accuracy and completeness of its contents.
Important Note:
● Cash Dividend Per Share before and after Tax Deduction
Units: yuan
cash dividend per share (before tax deduction) |
0.25 |
cash dividend per share (after tax deduction) |
0.2375 |
● equity registration date
Equity registration date |
2015 July 30 |
● ex-rights (ex-dividend) date: 2015# July 31, 92
● Cash Dividend Payment Date| Cash Dividend Payment Date |
2015# July 31, 108 |
1.
Shareholders who passed the distribution plan the session and time of the general meetingZhejiang jianfeng group co., ltd. 2014
annual profit distribution plan was reviewed and approved by the company's 2014 annual shareholders' meeting held on June 9, 2015. The announcement of the resolution of the general meeting of shareholders was published in China Securities Journal, Shanghai Securities News and the website of Shanghai Stock Exchange (http://www.sse.com.cn ) on June 10, 2015.
2.
Distribution Plan(I)
Issuance Year: 2014Year (II)
Issuance Scope:End of 2015
After closing in Shanghai Stock Exchange on the afternoon of July 30,, in Shanghai Branch of China Securities Depository and Clearing Corporation Limited (hereinafter referred to: zhongdeng Shanghai Branch) registered all shareholders of the Company.This distribution is based on 344,083,828 shares of 2014
at the end of the year. A cash dividend of 2.5 yuan (tax included) will be distributed to all shareholders for every 10 shares, and a cash dividend of 2.375 yuan will be distributed for every 10 shares after tax deduction. A total dividend of86,020,957.00 yuan was distributed. (III)
Tax Deduction Statement1
. For cash dividends of individual shareholders (including securities investment funds), the company temporarily withholds personal income tax at a tax rate of 5% according to the relevant provisions of the Notice on Issues Related to the Implementation of Differentiated Individual Income Tax Policies for Dividends of Listed Companies (Caishui [2012] No. 85), after tax deduction, the actual cash dividend per share is 0.2375 yuan. If the shareholder's holding period is less than 1 month (including 1 month), the full amount of dividend income shall be included in the taxable income, and the actual tax rate shall be 20%; if the holding period is more than 1 month to 1 year (including 1 year), the actual tax rate shall be 10%; if the holding period exceeds 1 year, the actual tax rate shall be 5%. When individuals (including securities investment funds) transfer stocks, Zhongdeng Shanghai Branch calculates the actual tax payable according to its shareholding period. The part exceeding the withheld tax will be deducted from the personal fund account by the securities company and other share custodian institutions. And transfer to Zhongdeng Shanghai Branch, Zhongdeng Shanghai Branch will transfer to the company within 5 working days of the following month, and the company will report and pay the tax to the competent tax authority within the statutory reporting period of the month of the month. 2
,For the cash dividends of Qualified Foreign Institutional Investors (QFII ), according to the relevant provisions of the "Regarding the Payment of Dividends, Dividends, and Interest to QFII by Chinese Resident Enterprises" Notice "(Guoshuihan [2009] No. 47) (hereinafter referred to as" Notice "), the company withholds and pays corporate income tax at a tax rate of 10%, and the actual cash dividend per share after tax deduction is 0.225 yuan. If the relevant shareholder considers that the dividend income received by him is subject to any tax treaty (arrangement) treatment, the shareholder may, in accordance with the provisions of the Notice, apply to the competent tax authorities on his own initiative after the dividend has been received. 3
. For investors (including enterprises and individuals) investing in the company Ashares ("Shanghai Stock Connect") on the Hong Kong Stock Exchange, the cash dividend will be distributed by the company through Zhongdeng Shanghai Branch in RMB according to the account of the nominal holder of the shares, tax deduction is implemented in accordance with the "Notice of the Ministry of Finance, the State Administration of Taxation, and the China Securities Regulatory Commission on the Relevant Tax Policies for the Pilot Interconnection Mechanism of Shanghai and Hong Kong Stock Market Transactions" (Caishui [2014] No. 81). The actual cash dividend per share is RMB 0.225. 4
. For company shareholders (including institutional investors) who belong to the meaning of resident enterprises under the Enterprise Income Tax Law, their income tax shall be paid by themselves, and the actual cash dividend shall be 0.25 yuan per share. 3.
distribution plan implementation date(I)
equity registration date| 30 |
(III) Cash Dividend Payment Date
223# July 31, 224 |
4. Distribution Object |
5. Dividends Implementation Measures
(I) The cash dividends of Jinhua Tongji State-owned Assets Investment Co., Ltd., a shareholder of the Company, are directly distributed by the Company.
(II) the cash dividends of other shareholders of the company other than Jinhua Tongji State-owned Assets Investment Co., Ltd., the company entrusts Zhongdeng Shanghai Branch to register and register with the Shanghai Stock Exchange through its capital clearing system. Distribute to shareholders who have handled designated transactions. Investors who have completed a fully designated transaction may receive cash dividends at their designated securities business department on the dividend payment date, while shareholders' dividends that have not completed the designated transaction are temporarily kept by Zhongdeng Shanghai Branch and will be distributed after the designated transaction is completed.
6.
Relevant Consultation Measures
Address: Office of the Board of Directors of Jianfeng Building, 88
Wujiang East Road, Jinhua City, Zhejiang ProvinceTel: 0579-82324699
; Fax: 0579-823246997. Reference Document Catalog
Resolution and Announcement of the Company's 2014
Annual General Meeting.Zhejiang Jianfeng Group Co., Ltd.
Board of Directors2015# July 27, 284
More information
2020
11-03
Jinhua Municipal Party Committee Secretary Chen Long: I wish your enterprise better and better
On the morning of October 16, Chen long, secretary of the Jinhua Municipal CPC Committee, and his entourage came to the construction site of Jianfeng Pharmaceutical's internationalization project to investigate and affirmed the good development status and clear future development ideas of Jianfeng Pharmaceutical. At the construction site, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, introduced the overall situation of the investment scale, factory layout, and production direction of the Jianfeng Pharmaceutical internationalization project to Chen Long and his entourage. Huang Jinlong, general manager of the pharmaceutical company, accompanied Chen Long and his entourage to visit the preparation workshop under construction. The construction site is neat, tidy and orderly, and the facilities and equipment are perfect and advanced, all have been unanimously affirmed by the leaders who came to investigate. When learning that the peak internationalization project has introduced international advanced equipment, built in accordance with European and American standards, and its products are oriented to the international market, Chen long said happily: "your goals are very clear and your thinking is very clear. I wish your enterprise better and better!" (this newspaper reporter)
2020
10-23
Liu Haiping, vice mayor of Pu'er City, said during the survey: "Peak is an enterprise with feelings"
On September 30, Liu Haiping, member of the standing Committee of the Pu'er Municipal CPC Committee and vice mayor of Pu'er City, Yunnan Province, and relevant responsible persons of Pu'er City and Simao District, visited the company for investigation and research, and communicated with the leaders of the group company on topics such as further strengthening cooperation between the two sides. "Yunnan Jianfeng has not only developed well in Pu'er these years, achieved good benefits and contributed considerable tax revenue, but also made great contributions to promoting the economic development of Pu'er and the stability of the southwest border region. It is our 'star enterprise' and 'baby enterprise '." Liu Haiping said so in the exchange. He said that Pu'er is an important window for the implementation of the "Belt and Road" concept. It has good conditions in natural resources, transportation, electricity, etc., and the peak is a "sentimental enterprise" and has a good foundation in the local area. Strengthen cooperation; various government departments will also earnestly "stand on the platform" and "do a good job as a shopkeeper" to serve enterprises. Chairman Jiang Xiaomeng and General Manager Yu Jianhong exchanged views with Liu Haiping and his party on the layout of peak industry and strengthening cooperation with Pu 'er. After that, accompanied by General Manager Yu Jianhong and Deputy General Manager Huang Jinlong, Liu Haiping and his party visited the Jinxi Factory of Jianfeng Pharmaceutical Factory. (this newspaper reporter)
2020
10-09
The first batch of Jianfeng Pharmaceuticals to enter Jinhua (Shanghai) Science and Technology Center
News from our newspaper On September 16, at the unveiling ceremony of the Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Innovation Center and Jinhua (Shanghai) Talent Building, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, took over from Chen Long, secretary of the Jinhua Municipal Party Committee. The golden key with big red flowers. Spike Pharmaceuticals became one of the first seven companies to enter the center. The Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Center and Jinhua (Shanghai) Talent Building are the first "Science and Technology and Talent Enclave" in Shanghai in the nine cities of the Yangtze River Delta G60 Science and Technology Corridor, and the first cross-regional industrial collaborative innovation center in the Science and Technology Corridor. The center is located in Shanghai Lingang Songjiang Science and Technology City, with a total area of nearly 10,000 square meters. It includes two parts: science and technology innovation and talent service. There are five major centers, including talent service center, science and technology innovation exhibition center, business incubation center, enterprise research and development center, and talent project roadshow center. It is a science and technology innovation platform that integrates the functions of project incubation, recruitment of institutions, and talent recruitment. Chen Long, secretary of the Jinhua Municipal Party Committee, said in his speech at the unveiling ceremony that in the future, all scientific and technological enterprises stationed in Jinhua (Shanghai) Science and Technology Center and Talent Building can equally enjoy Jinhua's local science and technology and talent policies, so as to further break the space limitation, enable talents from the two places to share the most favorable treatment and convenient services, help enterprises to develop in Shanghai and achieve industrialization in Jinhua. At the ceremony, leaders such as Chen Long, secretary of the Jinhua Municipal Party Committee, and Cheng Xiangmin, secretary of the Shanghai Songjiang District Party Committee, awarded seven companies, including Jianfeng Pharmaceutical, the golden key to symbolize their entry. At the Yangtze River Delta Integrated Talent Cooperation Project Symposium held after the ceremony, Jiang Xiaomeng spoke as a representative of Jinhua entrepreneurs. He believed that Shanghai, as an international metropolis, has an agglomeration effect on high-end intellectual resources and grasps the first-class element resources of scientific and technological innovation in China and even the world. The establishment of G60 Jinhua (Shanghai) science and technology innovation center and talent building in the Yangtze River Delta helps Jinhua enterprises to take off in scientific and technological innovation and information exchange, which will provide strong and continuous scientific and technological support and intellectual support for the long-term development of enterprises in the future, and attract more excellent domestic and foreign talents to serve Jinhua enterprises, It plays a key role in further improving scientific research ability, innovation ability and personnel training. During the event, Jiang Xiaomeng successively accepted on-site interviews with "People's Daily", "Liberation Daily", "Zhejiang Daily" and other media. He said that the establishment of science and technology innovation and talent bases in Shanghai has greatly enhanced Jinhua's attractiveness to enterprises. "With this base, we don't need to introduce talents to Jinhua, but directly recruit talents in Shanghai, and at the same time enjoy Jinhua's various talent recruitment policies, and change Shanghai talents to Jinhua's use. This is a kind of bold. The innovation has greatly solved the dilemma of attracting talents for enterprises." As a settled enterprise, it will also make full use of its own advantages to continuously inject resource vitality into the science and technology innovation center, and continue to contribute to the long-term development of Jinhua's economy. (this newspaper reporter)
2020
09-22
Spike Pharmaceutical Added New Products
On September 3, Spike Pharmaceutical Company received the approval of the State Drug Administration for the registration of esomeprazole sodium for injection (approval number: 2020S00572). Esomeprazole sodium for injection is mainly used to treat low-risk patients with gastroesophageal reflux disease and acute gastric or duodenal ulcer bleeding when oral therapy is not applicable. It has been listed in the National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List (2017 Edition) ", classified as Class B. According to industry statistics, 30 companies including Zhengda Tianqing and Qilu Pharmaceutical have been approved for listing in China. In 2019, domestic sales (including urban and county-level public hospitals, community and township health centers) were about 3.317 billion yuan. Jianfeng Pharmaceutical submitted an application for registration of esomeprazole sodium for injection to the State Food and Drug Administration in November 2013 and was accepted. Up to now, Jianfeng Pharmaceutical has invested nearly 15 million yuan in research and development for the project and has a corresponding production line. This time to obtain the injection of esomeprazole sodium drug registration approval, marking the peak pharmaceutical has the drug production, sales qualification, will further enrich the peak pharmaceutical product line, help to enhance the competitiveness of the peak pharmaceutical business. (Lu Yating, Liu Yang)
2020
09-11
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page